Literature DB >> 12952808

Aldosterone blockade after myocardial infarction.

Daniel G Hackam1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952808      PMCID: PMC183302     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.

Authors:  William B White; Daniel Duprez; Richard St Hillaire; Scott Krause; Barbara Roniker; Janice Kuse-Hamilton; Michael A Weber
Journal:  Hypertension       Date:  2003-04-07       Impact factor: 10.190

2.  Aldosterone induces a vascular inflammatory phenotype in the rat heart.

Authors:  Ricardo Rocha; Amy E Rudolph; Gregory E Frierdich; Denise A Nachowiak; Beverly K Kekec; Eric A G Blomme; Ellen G McMahon; John A Delyani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

3.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

4.  Heart failure after myocardial infarction: a review.

Authors:  Jens P Hellermann; Steven J Jacobsen; Bernard J Gersh; Richard J Rodeheffer; Guy S Reeder; Véronique L Roger
Journal:  Am J Med       Date:  2002-09       Impact factor: 4.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.